Shamburg News · 8-K filed Oct 22, 2026, 5:20 PM EDT

NeOnc Reports Early Clinical Improvement in Child Treated with NEO100 in Abu Dhabi

NTHI · NEONC TECHNOLOGIES HOLDINGS, INC.

  • Other event
  • Reg FD disclosure
  • Materiality: low

NeOnc Technologies Holdings, Inc. furnished three press releases under Item 7.01 dated October 16, 2026, October 21, 2026, and October 22, 2026. The October 16 release reported early clinical improvement in one critically ill three-year-old patient treated with investigational intranasal NEO100 through the Compassionate Care program in Abu Dhabi, with the company stating these observations do not establish efficacy or safety. The October 21 release announced a Memorandum of Understanding with the Department of Health - Abu Dhabi on research and clinical capability in oncology and CNS therapeutics, and the October 22 release announced a feature on Health Uncensored with Dr. Drew.

Read the filing on EDGAR ↗

Source: SEC EDGAR, Form 8-K, Items 7.01, 9.01, accession 0001829126-26-011446.

Written from the filing by Shamburg Markets. Figures are as reported by the company.